Living Cell Technologies Limited, a biotechnology company, focuses on developing living cell products for the treatment of diabetes, neurological disease, and haemophilia. Its product pipeline includes DIABECELL, neo-natal porcine pancreatic islet cells encapsulated in alginate and implanted to regulate blood glucose levels in Type I diabetics; and NTCELL, porcine choroid plexus cells encapsulated in alginate and implanted to protect and regenerate brain and nerve tissue for various neurological disorders. The company's Encapsulation technology is a proprietary gel that coats the pig cells to form micro-capsules ready for implant. It operates in New Zealand, Russia, and the United States